0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 1,000,001 1,000,001 1,000,001 xbrli:pure xbrli:shares iso4217:GBP 09589953 2023-01-01 2023-12-31 09589953 2023-12-31 09589953 2022-12-31 09589953 2022-01-01 2022-12-31 09589953 2022-12-31 09589953 2021-12-31 09589953 bus:Director3 2023-01-01 2023-12-31 09589953 core:WithinOneYear 2022-12-31 09589953 core:ShareCapital 2023-12-31 09589953 core:ShareCapital 2022-12-31 09589953 core:SharePremium 2023-12-31 09589953 core:SharePremium 2022-12-31 09589953 core:RetainedEarningsAccumulatedLosses 2023-12-31 09589953 core:RetainedEarningsAccumulatedLosses 2022-12-31 09589953 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 09589953 core:Non-currentFinancialInstruments 2023-12-31 09589953 core:Non-currentFinancialInstruments 2022-12-31 09589953 bus:SmallEntities 2023-01-01 2023-12-31 09589953 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 09589953 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 09589953 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 09589953 bus:FullAccounts 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 09589953
Chemisphere UK Holdings Limited
Filleted Unaudited Financial Statements
31 December 2023
Chemisphere UK Holdings Limited
Statement of Financial Position
31 December 2023
2023
2022
Note
£
£
£
Fixed assets
Investments
3
1,000,001
1,000,001
Current assets
Debtors
4
20
20
Cash at bank and in hand
3,369
9,987
------
-------
3,389
10,007
Creditors: amounts falling due within one year
5
31,296
------
-------
Net current assets/(liabilities)
3,389
( 21,289)
-----------
-----------
Total assets less current liabilities
1,003,390
978,712
Accruals and deferred income
1,295
802
-----------
--------
Net assets
1,002,095
977,910
-----------
--------
Capital and reserves
Called up share capital
6
1,000
1,000
Share premium account
9
9
Profit and loss account
1,001,086
976,901
-----------
--------
Shareholders funds
1,002,095
977,910
-----------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Chemisphere UK Holdings Limited
Statement of Financial Position (continued)
31 December 2023
These financial statements were approved by the board of directors and authorised for issue on 23 September 2024 , and are signed on behalf of the board by:
Mr. W.P. Worsley
Director
Company registration number: 09589953
Chemisphere UK Holdings Limited
Notes to the Financial Statements
Year ended 31 December 2023
1. General information
The company is a private company limited by shares, incorporated and registered in England and Wales with company number 09589953 . The address of the registered office is Unit 7 - 8, Severnside Trading Estate, Textilose Road, Trafford Park, Manchester M17 1WA
2. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the company and rounded to the nearest £.
Consolidation
The entity has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the entity and its subsidiary undertakings comprise a small group. These accounts cover the individual entity alone and not the group.
Judgements in applying accounting policies and key sources of estimation in uncertainty
In preparing these financial statements the directors have had to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historic experience and various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates. For this reporting date there are no significant judgements, estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amounts of the assets and liabilities.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
The company only has basic financial instruments. - Financial assets Financial assets comprise items such as cash at bank and in hand and trade and other debtors. These are initially recorded at cost on the date they originate, the company considers evidence of impairment for all individual elements comprising financial assets and any subsequent impairment is recognised in profit and loss. - Financial liabilities Financial liabilities comprise items such as corporation and other taxes, bank and other loans, accruals and trade and other creditors. These are initially recorded at cost on the date they originate, net of transaction costs where applicable, the company considers evidence of impairment for all individual elements comprising financial liabilities and any subsequent impairment is recognised in profit and loss.
3. Investments
Shares in group undertakings
£
Cost
At 1 January 2023 and 31 December 2023
1,000,001
-----------
Impairment
At 1 January 2023 and 31 December 2023
-----------
Carrying amount
At 31 December 2023
1,000,001
-----------
At 31 December 2022
1,000,001
-----------
The company owns 100% of the issued share capital of the companies listed below:
Chemisphere UK Limited
Beer Piper International Limited
Under the provision of section 398 of the Companies Act 2006 the company is exempt from preparing consolidated accounts and has not done so, therefore the accounts show information about the company as an individual entity.
4. Debtors
2023
2022
£
£
Other debtors
20
20
----
----
5. Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
31,296
----
-------
John Taylor holds a fixed and floating charge over all property and undertakings of the company dated 21 December 2023.
6. Called up share capital
2023
2020
£
£
Ordinary shares of £0.01 each
100,000
1,000
100,000
1,000
A1 Ordinary shares of £0.01 each
1
1
A2 Ordinary shares of £0.01 each
1
1
A3 Ordinary shares of £0.01 each
1
1
A4 Ordinary shares of £0.01 each
1
1
A5 Ordinary shares of £0.01 each
1
1
A6 Ordinary shares of £0.01 each
1
1
A7 Ordinary shares of £0.01 each
1
A8 Ordinary shares of £0.01 each
1
--------
------
--------
------
100,008
1,000
100,006
1,000
--------
------
--------
------
7. Controlling party
The ultimate parent company is Chemisphere UK Holdings 2023 Limited, a company registered in England and Wales.